Edmund G. Wee

1.9k citations

29 papers · 1.2k indexed · h-index 18

Virology top 1%
- HIV Research and Treatment 21
Immunology top 5%
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 5
Infectious Diseases top 10%
Molecular Biology top 10%
- vaccines and immunoinformatics approaches 10
- Glycosylation and Glycoproteins Research 2
Cell Biology top 10%
- Cellular transport and secretion 3
Genetics
- Virus-based gene therapy research 6
Epidemiology
- Virology and Viral Diseases 3

Co-authors: Tomáš Hanke Andrew J. McMichael D. Janine Sherrier Tracy A. Prime Paul Dupree Sandip Pravin Patel Nathifa Moyo Søren Buus
Cited by: Virology Immunology Infectious Diseases
Journals: Nature Immunology (1 paper)PLoS ONE (3 papers)The Plant Cell (3 papers)
Partner nations: United Kingdom Japan United States

In The Last Decade

Edmund G. Wee

28 papers receiving 1.2k citations

Peers

Countries citing papers authored by Edmund G. Wee

Since Specialization

Citations

This map shows the geographic impact of Edmund G. Wee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmund G. Wee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmund G. Wee more than expected).

Fields of papers citing papers by Edmund G. Wee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edmund G. Wee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmund G. Wee. The network helps show where Edmund G. Wee may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Edmund G. Wee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edmund G. Wee Line = papers co-authored together Edmund G. Wee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa Frontiers in Immunology ·Ashley C. Beavis,Edmund G. Wee,Belkis M. Akis Yildirim,Nicola Borthwick,Biao He,Tomáš Hanke	2023	1
2	Adenovirus Transcriptome in Human Cells Infected with ChAdOx1-Vectored Candidate HIV-1 Vaccine Is Dominated by High Levels of Correctly Spliced HIVconsv1&62 Transgene RNA Vaccines ·David A. Matthews,Rachel Milligan,Edmund G. Wee,Tomáš Hanke	2023	0
3	Epitope length variants balance protective immune responses and viral escape in HIV-1 infection Cell Reports ·Phillip Pymm,Stefan Tenzer,Edmund G. Wee,Mirjana Weimershaus,Anne Burgevin,Simon Kollnberger,Jan Gerstoft,Tracy M. Josephs,Kristin Ladell,James E. McLaren,Victor Appay,David A. Price,Lars Fugger,John I. Bell,Hansjörg Schild,Peter Van Endert,Maria Harkiolaki,Astrid K. N. Iversen	2022	3
4	Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines Molecular Therapy — Methods & Clinical Development ·Edmund G. Wee,Nathifa Moyo,Zara Hannoun,Elena Giorgi,Bette Korber,Tomáš Hanke	2021	9
5	Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth Vaccines ·Nathifa Moyo,Edmund G. Wee,Bette Korber,Kapil Bahl,Samantha Falcone,Sunny Himansu,Adrianne L. Wong,Antu Dey,Mark B. Feinberg,Tomáš Hanke	2020	18
6	Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice Frontiers in Immunology ·Athina Kilpeläinen,Narcı́s Saubi,Núria Guitart,Nathifa Moyo,Edmund G. Wee,Krupa Ravi,Tomáš Hanke,Joan Joseph	2019	17
7	Complete protection of the BALB/c and C57BL/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine PLoS Pathogens ·Md Niaz Rahim,Edmund G. Wee,Shihua He,Jonathan Audet,Kevin Tierney,Nathifa Moyo,Zara Hannoun,Alison Crook,Andrea Baines,Bette Korber,Xiangguo Qiu,Tomáš Hanke	2019	19
8	Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1 Molecular Therapy — Methods & Clinical Development ·Edmund G. Wee,Nathifa Moyo,Kevin O. Saunders,Celia C. LaBranche,Filippo Donati,Silvia Capucci,Robert Parks,Nicola Borthwick,Zara Hannoun,David C. Montefiori,Barton F. Haynes,Tomáš Hanke	2019	4
9	Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA Molecular Therapy — Methods & Clinical Development ·Nathifa Moyo,Annette B. Vogel,Søren Buus,Stephanie Erbar,Edmund G. Wee,Uğur Şahin,Tomáš Hanke	2018	79
10	Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1 PLoS ONE ·Nicola Borthwick,Thirusha Lane,Nathifa Moyo,Alison Crook,Jung Min Shim,Ian A. Baines,Edmund G. Wee,Philip N. Hawkins,Julian D. Gillmore,Tomáš Hanke,M B Pepys	2018	11
11	HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells Molecular Therapy ·Edmund G. Wee,Beatrice Ondondo,Peter Berglund,Jacob Archer,Andrew J. McMichael,David Baltimore,Jan H. ter Meulen,Tomáš Hanke	2017	18
12	HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers PLoS ONE ·Silvia Capucci,Edmund G. Wee,Torben Schiffner,Celia C. LaBranche,Nicola Borthwick,Albert Cupo,Jonathan Dodd,Hansi Dean,Quentin J. Sattentau,David C. Montefiori,Per Johan Klasse,Rogier W. Sanders,John P. Moore,Tomáš Hanke	2017	12
13	Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection Molecular Therapy ·Beatrice Ondondo,Hayato Murakoshi,Genevieve Clutton,Sultan Abdul-Jawad,Edmund G. Wee,Hiroyuki Gatanaga,Shinichi Oka,Andrew J. McMichael,Masafumi Takiguchi,Bette Korber,Tomáš Hanke	2016	89
14	APOBEC3G-Induced Hypermutation of Human Immunodeficiency Virus Type-1 Is Typically a Discrete “All or Nothing” Phenomenon PLoS Genetics ·Andrew E. Armitage,Koen Deforche,Chih‐Hao Chang,Edmund G. Wee,Beatrice Kramer,John J. Welch,Jan Gerstoft,Lars Fugger,Andrew J. McMichael,Andrew Rambaut,Astrid K. N. Iversen	2012	60
15	Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance Nature Immunology ·Stefan Tenzer,Edmund G. Wee,Anne Burgevin,Guillaume Stewart-Jones,Lone Smidstrup Friis,Kasper Lamberth,Chih‐Hao Chang,Mikkel Harndahl,Mirjana Weimershaus,Jan Gerstoft,Nadja Akkad,Paul Klenerman,Lars Fugger,E. Yvonne Jones,AJ McMichael,Søren Buus,Hansjörg Schild,Peter Van Endert,Iversen Akn.	2009	155
16	Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants Vaccine ·Jennifer A. Slyker,Barbara L. Lohman,Dorothy Mbori‐Ngacha,Marie Reilly,Edmund G. Wee,Tao Dong,Andrew J. McMichael,Sarah Rowland‐Jones,Tomáš Hanke,Grace John‐Stewart	2005	20
17	Protein microarray analysis of p53-mediated apoptosis; identification of potential tumour associated antigens British Journal of Dermatology ·Black Apb.,Louise Jones,Edmund G. Wee,Simon Kollnberger,Sanjeewa Seneviratne,Graham S. Ogg	2003	1
18	Construction and immunogenicity in a prime–boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine Journal of General Virology ·Tomáš Hanke,Christina Barnfield,Edmund G. Wee,Lena Ågren,Rachel V. Samuel,Natasha Larke,Peter Liljeström	2003	46
19	Development of a DNA-MVA/HIVA vaccine for Kenya Vaccine ·Tomáš Hanke,Andrew J. McMichael,Matilu Mwau,Edmund G. Wee,Inese Ceberej,Sandip Pravin Patel,Julian Sutton,Maxine Tomlinson,Rachel V. Samuel	2002	59
20	Protein retention and localization in the endoplasmic reticulum and the Golgi apparatus Biochimie ·Véronique Gomord,Edmund G. Wee,Loı̈c Faye	1999	43

About Edmund G. Wee

Edmund G. Wee is a scholar working on Virology, Immunology and Molecular Biology, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (21 papers), vaccines and immunoinformatics approaches (10 papers), Immunotherapy and Immune Responses (7 papers), Virus-based gene therapy research (6 papers), Immune Cell Function and Interaction (5 papers), Virology and Viral Diseases (3 papers), Cellular transport and secretion (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Virology (550 citations), Immunology (533 citations) and Infectious Diseases (237 citations). Edmund G. Wee has collaborated with scholars based in United Kingdom, Japan and United States. Frequent co-authors include Tomáš Hanke, Andrew J. McMichael, D. Janine Sherrier, Tracy A. Prime, Paul Dupree, Sandip Pravin Patel, Nathifa Moyo, Søren Buus, Julian Sutton and Matilu Mwau. Their work appears in journals such as Nature Immunology, PLoS ONE and The Plant Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact